Potential dilution from the exercise of stock acquisition rights
First written in FY2023. 8 of 9 entries say "Materialised", first in FY2024-Q1. Latest entry: FY2026.
Rebase moved to the "Worse" side of this theme in 2023, 2 years after the typical company in this theme (2021).
The whole theme swung hardest in 2017: 28 of 54 companies on the "Worse" side.
56 other companies' latest entry also says "Materialised".
- FY2026MaterialisedAnnual report
「1 April 2025–31 March 2026 (Note) 4 Common shares 3,300 Common shares 4,916,000」
3,300 shares were issued through exercise of stock acquisition rights during the fiscal year. The issuance of 50,000 paid stock acquisition rights in Series 6 resulted in potential shares of 108,550 as of the filing date, equivalent to 2.21% of issued shares. - FY2026-H1MaterialisedAnnual report
「1 April 2025–30 September 2025 (Note) 2,200 4,914,900 (Note) Increase due to exercise of stock acquisition rights.」
2,200 shares were issued through exercise of stock acquisition rights during the interim accounting period, bringing total issued shares to 4,914,900. - FY2025MaterialisedAnnual report
「1 April 2024–31 March 2025 Common shares 305,000 Common shares 4,912,700 As of the filing date, the number of common shares underlying stock acquisition rights was 65,150, equivalent to 1.33% of the company's 4,912,700 issued shares.」
305,000 shares were issued through exercise of stock acquisition rights during the fiscal year. As of the filing date, remaining potential shares were 65,150, equivalent to 1.33% of issued shares. - FY2025-H1MaterialisedAnnual report
「1 April 2024–30 September 2024 (Note) 7,150 4,614,850」
7,150 shares were issued through exercise of stock acquisition rights during the interim accounting period, bringing total issued shares to 4,614,850. A further 10,450 shares were issued from 1 October to 31 October 2024. - FY2024MaterialisedAnnual report
「1 April 2023–31 March 2024 (Note) Common shares 7,700; common shares 4,607,700」
7,700 shares were issued through exercise of stock acquisition rights during the fiscal year. As of the filing date, potential shares under stock acquisition rights were 370,700, equivalent to 8.04% of issued shares. - FY2024-Q3MaterialisedAnnual report
「1 October 2023–31 December 2023 (Note) 1,100 4,607,700 82 167,967 82 167,717」
1,100 shares were added during the third quarter through exercise of stock acquisition rights, bringing total issued shares to 4,607,700. - FY2024-Q2MaterialisedAnnual report
「Increase (decrease) in total issued shares 2,200 shares (Note) Increase due to exercise of stock acquisition rights.」
From July through September 2023, 2,200 shares were added to issued shares through exercise of stock acquisition rights, realizing part of the potential dilution. - FY2024-Q1MaterialisedAnnual report
「1 April 2023–30 June 2023 (Note 1) 4,400; total issued shares 4,604,400」
4,400 shares were issued through exercise of stock acquisition rights during the quarter, realizing part of the potential dilution. - FY2023First statedAnnual report
「As of the filing date, the number of common shares underlying stock acquisition rights was 375,100, equivalent to 8.15% of the company's 4,604,400 issued shares. If these stock acquisition rights, or rights granted in the future, are exercised, they may dilute the value of the company's shares.」
Discloses potential dilution from existing and future stock-option exercises, quantified at 8.15%.